Browsing by Author Rodríguez-Abreu, Delvys

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 5 of 5
TitleAuthor(s)Issue Date
 
Five-Year Outcomes with Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer with PD-L1 Tumor Proportion Score ‡ 50%
Journal:Journal of Clinical Oncology
Reck, MartinRodríguez-Abreu, DelvysRobinson, Andrew G.Hui, RinaCsöszi, TiborFülöp, AndreaGottfried, MayaPeled, NirTafreshi, AliCuffe, SineadO’Brien, MaryRao, SumanHotta, KatsuyukiLeal, Ticiana A.Riess, Jonathan W.Jensen, ErinZhao, BinPietanza, M. CatherineBrahmer, Julie R.
2021
 
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Journal:The Lancet Oncology
Brahmer, Julie R.Rodríguez-Abreu, DelvysRobinson, Andrew G.Hui, RinaCsőszi, TiborFülöp, AndreaGottfried, MayaPeled, NirTafreshi, AliCuffe, SineadO'Brien, MaryRao, SumanHotta, KatsuyukiZhang, JinLubiniecki, Gregory M.Deitz, Anne C.Rangwala, ReshmaReck, Martin
2017
 
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Journal:The Lancet Oncology
Garassino, Marina C.Gadgeel, ShirishEsteban, EmilioFelip, EnriquetaSperanza, GiovannaDomine, ManuelHochmair, Maximilian J.Powell, StevenCheng, Susanna Yee ShanBischoff, Helge G.Peled, NirReck, MartinHui, RinaGaron, Edward B.Boyer, MichaelWei, ZiwenBurke, ThomasPietanza, M. CatherineRodríguez-Abreu, Delvys
2020
 
Updated analysis from KEYNOTE-189: Pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non–small-cell lung cancer
Journal:Journal of Clinical Oncology
Gadgeel, ShirishRodríguez-Abreu, DelvysSperanza, GiovannaEsteban, EmilioFelip, EnriquetaDómine, ManuelHui, RinaHochmair, Maximilian J.Clingan, PhilipPowell, Steven F.Yee-Shan Cheng, SusannaBischoff, Helge G.Peled, NirGrossi, FrancescoJennens, Ross R.Reck, MartinGaron, Edward B.Novello, SilviaRubio-Viqueira, BelénBoyer, MichaelKurata, TakayasuGray, Jhanelle E.Yang, JingBas, TubaPietanza, M. CatherineGarassino, Marina C.
2020
 
Updated analysis of KEYNOTE-024: Pembrolizumab versus platinum-based chemotherapy for advanced non–small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater
Journal:Journal of Clinical Oncology
Reck, MartinRodríguez-Abreu, DelvysRobinson, Andrew G.Hui, RinaCsoszi, TiborFülöp, AndreaGottfried, MayaPeled, NirTafreshi, AliCuffe, SineadO’Brien, MaryRao, SumanHotta, KatsuyukiVandormael, KristelRiccio, AntonioYang, JingCatherine Pietanza, M.Brahmer, Julie R.
2019
Showing results 1 to 5 of 5